[1] Gilhus N E, Verschuuren J J. Myasthenia gravis: subgroup classification and therapeutic strategies[J]. Lancet Neurol, 2015,14(10):1023-1036.
[2] Hehir M K, Silvestri N J. Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology[J]. Neurol Clin, 2018, 36(2): 253-260.
[3] 中华医学会神经病学分会神经免疫学组. 重症肌无力诊断和治疗中国专家共识[J]. 中国神经免疫学和神经病学杂志,2012,19(6):401-408.
[4] 夏 强,刘卫彬,冯慧宇,等.胸腺成熟树突状细胞与重症肌无力发生的相关性分析[J],中华医学杂志,2008,88(47):3349-3351.
[5] 李海峰,张 栩,从志强.重症肌无力发生与发展的临床流行病学研究[J].临床神经病学杂志,2006,19(6):468-470.
[6] Benatar M.A systematic review of diagnostic studies in myasthenia ravis[J].Neuromuseul Disord,2006,16(7):459-467.
[7] Goya R G, Sosa Y E, Cónsole G M, et al. Altered thyrotropic and somatotropic responses to environmental challenges in congenitally athymic mice[J]. Brain Behav Immun, 1995,9(2):79-86.
[8] Kataoka H,Kiriyama T,Kawaguchi T,et al.Preoperative low dose steroid can prevent respiratory insufficiency after thymectomyin generalized myasthenia gravis[J].Ear Neurol,2014,72(3-4):228-233.
[9] Seybold M E.Thymeetomy in childhood myasthenia gravis[J].Ann N Y Aead Sci,1998,841:731-741.
[10] 王海燕,曾凡森,刘卫彬,等. 胸腺切除术对青少年重症肌无力患者生长发育的影响[J].中华医学杂志,2015,95(21):1671-1676.
[11] 李 言,刘卫彬,罗传铭,等. 胸腺手术治疗儿童重症肌无力的疗效随访及影响因素分析[J].中华医学杂志,2012,92(17):1170-1173.
[12] 魏 立,陈明耀,务 森,等. 双侧胸腔镜下治疗胸腺疾病的临床观察[J].中华医学杂志,2010,90(19):1326-1328.
[13] Masaoka A,Yamakawa Y,Niwa H,et al. Extended thymectomy for myasthenia gravis patients: a 20-year review [J]. Ann Thorac Surg,1996,62:853-859.
[14] Essa M,El-Medany Y,Hajjar W,et al.Maximal thymectomy in children with myasthenia gravis[J].Eur J Cardiothome Slug,2003,24:187-191.
[15] 王 伟,尚立群,文 峰,等. 胸腔切除治疗重症肌无力的疗效分析[J].中华医学杂志,2006,86(28):1978-1980.
[16] 门丽娜,刘卫彬,陈振光,等. 重症肌无力患者胸腺扩大切除术后复发的相关因素分析[J].中华医学杂志,2008,88(21):1446-1449.
[17] 刘卫彬. 应重视重症肌无力综合治疗的个体化[J].中华医学杂志,2009,89(43):3025-3027.